Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319460031> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4319460031 endingPage "107193" @default.
- W4319460031 startingPage "107193" @default.
- W4319460031 abstract "To explore the benefit of rapid induction with intravitreal bevacizumab for neovascular age-related macular degeneration (AMD).Single-institution prospective randomized pilot study.Patients with treatment-naïve neovascular AMD were randomized 1:1:1 into 1 of 3 groups based on the induction sequence: (1) every 2 weeks for 3 consecutive injections; (2) every 4 weeks for 3 consecutive injections; and (3) immediate pro re nata (prn) after the first injection. Retinal angiomatous proliferation and polypoidal choroidal vasculopathy were excluded. Best-corrected visual acuity (BCVA) and central retinal thickness using optical coherence tomography (OCT) were measured at baseline and at each follow-up. After induction, bevacizumab was administered as needed based mainly on OCT. Main outcome measure was mean initial fluid-free interval after induction. Secondary outcomes were mean improvement in BCVA and central retinal thickness.Each group included 30 patients (30 eyes). Mean initial fluid-free interval was 2.4, 3.4, and 3.5 months for biweekly induction, monthly induction, and immediate prn groups, respectively (P = .03). Significance was lost when corrected for age and sex (P = .073). Mean improvement in BCVA, central retinal thickness, and total number of injections were similar among the groups at 12 months. Six eyes in the biweekly induction group developed subretinal fibrosis vs no eyes in the other 2 groups (P = .003).Biweekly induction with intravitreal bevacizumab for treatment-naïve neovascular AMD does not increase initial fluid-free interval or cause significant anatomic and functional benefit compared to monthly induction or immediate prn. There is also the potential development of subretinal fibrosis with biweekly induction." @default.
- W4319460031 created "2023-02-09" @default.
- W4319460031 creator A5016606020 @default.
- W4319460031 creator A5036886965 @default.
- W4319460031 creator A5039317709 @default.
- W4319460031 creator A5090732038 @default.
- W4319460031 date "2023-02-01" @default.
- W4319460031 modified "2023-09-25" @default.
- W4319460031 title "AZ-3102 significantly increases survival and decreases neuroinflammation in a mouse model of Sandhoff disease" @default.
- W4319460031 doi "https://doi.org/10.1016/j.ymgme.2022.107193" @default.
- W4319460031 hasPublicationYear "2023" @default.
- W4319460031 type Work @default.
- W4319460031 citedByCount "0" @default.
- W4319460031 crossrefType "journal-article" @default.
- W4319460031 hasAuthorship W4319460031A5016606020 @default.
- W4319460031 hasAuthorship W4319460031A5036886965 @default.
- W4319460031 hasAuthorship W4319460031A5039317709 @default.
- W4319460031 hasAuthorship W4319460031A5090732038 @default.
- W4319460031 hasConcept C118487528 @default.
- W4319460031 hasConcept C141071460 @default.
- W4319460031 hasConcept C168563851 @default.
- W4319460031 hasConcept C2776403814 @default.
- W4319460031 hasConcept C2776694085 @default.
- W4319460031 hasConcept C2777802072 @default.
- W4319460031 hasConcept C2778257484 @default.
- W4319460031 hasConcept C2780699112 @default.
- W4319460031 hasConcept C2780827179 @default.
- W4319460031 hasConcept C2781100027 @default.
- W4319460031 hasConcept C71924100 @default.
- W4319460031 hasConceptScore W4319460031C118487528 @default.
- W4319460031 hasConceptScore W4319460031C141071460 @default.
- W4319460031 hasConceptScore W4319460031C168563851 @default.
- W4319460031 hasConceptScore W4319460031C2776403814 @default.
- W4319460031 hasConceptScore W4319460031C2776694085 @default.
- W4319460031 hasConceptScore W4319460031C2777802072 @default.
- W4319460031 hasConceptScore W4319460031C2778257484 @default.
- W4319460031 hasConceptScore W4319460031C2780699112 @default.
- W4319460031 hasConceptScore W4319460031C2780827179 @default.
- W4319460031 hasConceptScore W4319460031C2781100027 @default.
- W4319460031 hasConceptScore W4319460031C71924100 @default.
- W4319460031 hasIssue "2" @default.
- W4319460031 hasLocation W43194600311 @default.
- W4319460031 hasOpenAccess W4319460031 @default.
- W4319460031 hasPrimaryLocation W43194600311 @default.
- W4319460031 hasRelatedWork W1995044506 @default.
- W4319460031 hasRelatedWork W2034093159 @default.
- W4319460031 hasRelatedWork W2042956061 @default.
- W4319460031 hasRelatedWork W2068871928 @default.
- W4319460031 hasRelatedWork W2121621777 @default.
- W4319460031 hasRelatedWork W2312597636 @default.
- W4319460031 hasRelatedWork W2336111296 @default.
- W4319460031 hasRelatedWork W2559118752 @default.
- W4319460031 hasRelatedWork W2757502056 @default.
- W4319460031 hasRelatedWork W2946414584 @default.
- W4319460031 hasVolume "138" @default.
- W4319460031 isParatext "false" @default.
- W4319460031 isRetracted "false" @default.
- W4319460031 workType "article" @default.